Subcutaneous interleukin-4 for relapsed non-Hodgkin's lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.

被引：0
|
作者：
Kurtz, D. M. [1 ]
Tschetter, L. K. [1 ]
Allred, J. B. [1 ]
Geyer, S. M. [1 ]
Kurtin, P. J. [1 ]
Putnam, W. D. [1 ]
Rowland, K. M. [1 ]
Wiesenfeld, M. [1 ]
Soori, G. S. [1 ]
Tenglin, R. C. [1 ]
Bernath, A. M. [1 ]
Witzig, T. E. [1 ]
机构：
[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2007年 / 55卷 / 02期
关键词：
D O I：
10.1097/00042871-200703010-00088
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
81
引用
收藏
页码：S362 / S362
页数：1
相关论文
共 50 条
  • [11] A North Central Cancer Treatment Group Phase II Trial of Topotecan in Relapsed Gliomas
    Patrick A. Burch
    Albert M. Bernath
    Terrence L. Cascino
    Bernd W. Scheithauer
    Paul Novotny
    Suresh Nair
    Jan C. Buckner
    Delano M. Pfeifle
    John W. Kugler
    Loren K. Tschetter
    Investigational New Drugs, 2000, 18 : 275 - 280
  • [12] A phase II trial of FavId™ [Id-KLH] for relapsed indolent non-Hodgkin's Lymphoma
    Redfern, C
    Guthrie, TH
    Smith, MR
    Adler, M
    Holman, P
    Leonard, JP
    Levy, R
    Densmore, J
    Just, R
    Rosenfelt, F
    Wiernik, PH
    Janakiraman, N
    Winter, JN
    Gold, D
    Bender, JF
    BLOOD, 2002, 100 (11) : 357A - 357A
  • [13] Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: A phase II trial in the north central cancer treatment group
    Witzig, TE
    Vukov, AM
    Habermann, TM
    Geyer, S
    Kurtin, PJ
    Friedenberg, WR
    White, WL
    Chalchal, HI
    Flynn, PJ
    Fitch, TR
    Welker, DA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1103 - 1108
  • [14] Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
    Kirschbaum, Mark
    Frankel, Paul
    Popplewell, Leslie
    Zain, Jasmine
    Delioukina, Maria
    Pullarkat, Vinod
    Matsuoka, Deron
    Pulone, Bernadette
    Rotter, Arnold J.
    Espinoza-Delgado, Igor
    Nademanee, Auayporn
    Forman, Stephen J.
    Gandara, David
    Newman, Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) : 1198 - 1203
  • [15] Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: Final report of a phase II trial
    Younes, A
    Ayoub, JP
    Sarris, A
    Hagemeister, F
    North, L
    Pate, O
    McLaughlin, P
    Rodriguez, MA
    Romaguera, J
    Kurzrock, R
    Preti, A
    Bachier, C
    Smith, T
    Cabanillas, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 96 (02) : 328 - 332
  • [16] Phase II study of fludarabine and cyclophosphamide in the treatment of relapsed low grade non-Hodgkin's lymphoma.
    Lucie, NP
    Dunlop, DJ
    Soukop, M
    McKay, PJ
    Stark, AN
    Anderson, SM
    Paul, J
    BLOOD, 2001, 98 (11) : 606A - 607A
  • [17] Liposomal encapsulated doxorubicin (Caelyx) in the treatment of relapsed aggressive non-Hodgkin's lymphoma: A phase II study
    Macpherson, N.
    Belch, A.
    Taylor, M.
    Sutherland, J.
    Czaykowski, P.
    Connors, J.
    LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1327 - 1332
  • [18] A phase II trial of gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for patients with refractory or relapsed non-Hodgkin's lymphoma
    Park, B.
    Kim, W.
    Eom, H.
    Kim, J.
    Oh, S.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [19] Phase II trial of Doxil® in patients with refractory/relapsed low-grade non-Hodgkin's lymphoma.
    Di Bella, NJ
    Khan, MM
    Dakhil, SR
    Logie, KW
    Marsland, TA
    Simon, SR
    Weinstein, RE
    BLOOD, 2000, 96 (11) : 236B - 236B
  • [20] A PHASE II TRIAL OF GEMCITABINE, IFOSFAMIDE, DEXAMATHASONE, AND OXALIPLATIN (GIDOX) FOR PATIENTS WITH REFRACTORY OR RELAPSED NON-HODGKIN'S LYMPHOMA
    Park, B. B.
    Kim, W. S.
    Eom, H. S.
    Kim, J. S.
    Oh, S. J.
    Hwang, I. G.
    Suh, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 652 - 652
12345